SCHEMBL2475847

SCHEMBL2475847

CNC(=O)Nc1nc(N)nc(N(C)C)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.51
CA1 P00915 6/20 0.42
CA2 P00918 6/20 0.42
CA9 Q16790 6/20 0.42
CA12 O43570 5/20 0.42
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ADORA3 P0DMS8 2/20 0.35
ADORA2A P29274 2/20 0.35
ADORA1 P30542 2/20 0.35
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.33
PIK3R1 P27986 1/20 0.33
PIK3CA P42336 1/20 0.33
MTOR P42345 1/20 0.33
LMNA P02545 2/20 0.33
ALOX12 P18054 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2474178 0.88 POLB (0.60) POLBCA1CA2CA9CA12
SCHEMBL7186156 0.84 ALDH1A1 (0.39) POLBALDH1A1SMN1; SMN2PIK3R1PIK3CA
SCHEMBL2472999 0.84 ALDH1A1 (0.39) POLBCA1CA2CA9CA12
SCHEMBL2479016 0.79 POLB (0.54) POLBCA1CA2CA9CA12
Acetic Acid SCHEMBL28195268 0.78 POLB (0.49) POLBALDH1A1KDM4ESMN1; SMN2ADORA3
SCHEMBL32675859 0.76 LMNA (0.42) POLBCA1CA2CA9ALDH1A1
SCHEMBL60190 0.76 LMNA (0.42) POLBCA1CA2CA9ALDH1A1
Formaldehyde SCHEMBL6476807 0.75 POLB (0.40) POLBCA1CA2CA9ALDH1A1
SCHEMBL2478969 0.73 ALDH1A1 (0.46) POLBALDH1A1KDM4ESMN1; SMN2PIK3R1
Methylamine SCHEMBL17309971 0.73 PDE4A (0.40) POLBCA1CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373633-B1 METHOD FOR PRODUCING TRAZINE CARBAMATES USING CHLOROFORMATES BOREALIS AGROLINZ MELAMINE (AT) 2014-04-16 EP disclosed
US-20110295001-A1 Method for Producing Triazine Carbamates Using Chloroformates BOREALIS AGROLINZ MELAMINE GMBH (AT) 2011-12-01 US disclosed
EP-2373633-A1 METHOD FOR PRODUCING TRAZINE CARBAMATES USING CHLOROFORMATES Borealis Agrolinz Melamine GmbH (AT) 2011-10-12 EP disclosed
WO-2010066683-A1 METHOD FOR PRODUCING TRAZINE CARBAMATES USING CHLOROFORMATES BOREALIS AGROLINZ MELAMINE GMBH (AT) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110295001-A1 Method for Producing Triazine Carbamates Using Chloroformates CA3, CA7, KAT5 POLB 2669/4885CA1 10/4885CA2 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.